Current Risk Management Issues in Due Diligence

June 12, 2014
Thomson Reuters and Villanova University School of Law
Villanova University School of Law299 N. Spring Mill Road
Villanova, PA, PA 19085

8:45 a.m. to 4:15 p.m. (Reception to follow)

Alfred J. Monte, Jr. is participating in a special one-day forum presented by Thomson Reuters and Villanova University School of Law.

Panelists representing all sectors of the life sciences industry, including pharmaceutical, medical device, regulatory, legal and academia, will provide their insights on the cutting-edge issues facing publicly traded and privately held life sciences businesses.

Citing recent developments and sharing perspectives on key areas such as the Affordable Care Act, deal structures, domestic and foreign compliance concerns, new drug development strategies, competition/collaboration and cost, and current risk management issues, panelists will help business development executives, life sciences counsel and those in academia understand the impactful topics affecting the life sciences industry in 2014 and beyond.

In the session“Current Risk Management Issues in Due Diligence,” Fred, Jason and other speakers will highlight:

  • Product liability
  • Clinical trials
  • Legal developments regarding discount safe harbor
  • Global regulatory trends in pharmacovigilance

Alfred J. Monte, Jr. Esq.
Partner and Chair, Life Sciences Practice Group, Fox Rothschild LLP

David Dopf
Director and Senior Counsel, Boehringer Ingelheim Pharmaceuticals, Inc.

Jennine Foran
Chief Compliance Offices; Director of Risk Management, Norwalk Hospital

Elizabeth V. Jobes
Senior Vice President and Chief Compliance Officer, Auxilium Pharmaceuticals